The analysis of markers such as the uterine artery pulsatility index (UtAPI) and the evaluation of antiangiogenic and angiogenic factors (sFlt-1/ PIGF) are crucial in these cases to differentiate the two conditions.26Although the distinction between true preeclampsia and preeclampsia-like syndrome resulting from COVID-19 is not straightforward, efforts must be made to characterize each of these conditions in order to avoid interventions and induction of unnecessary childbirth.12, 31. Here, PIGF is linked to preeclampsia.